Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 562

The DOI matches its Crossref record.

Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome

Chiba, Atsuro, Kusunoki, Susumu, Shimizu, Teruo, Kanazawa, Ichiro·1992·Annals of Neurology

Abstract

We studied serum anti‐glycolipid antibodies by enzymelinked immunosorbent assay and thin‐layer chromatography–enzyme immunoassay in six consecutive patients with typical Miller Fisher syndrome. In all six, increased activity of IgG antibody against ganglioside GQ1b was present in the early phase and reduced with time, whereas such activity was not detected in normal control subjects and disease control subjects including those with Guillain‐Barrë syndrome. Anti‐GQ1b IgG antibody is a new possible diagnostic marker of Miller Fisher syndrome and could well be related to the disease process itself.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.410310619

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 562

Metadata

Authors
Chiba, A., Kusunoki, S., Shimizu, T., & Kanazawa, I.
Venue
Annals of Neurology
Publisher
Wiley
Published
1992-06
Volume
31
Issue
6
Pages
677-679
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2060838010
Cited by
562
References
0
FWCI
13.60
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. https://app.cochat.ai/papers/10.1002/ana.410310619
The paper
Chiba, A., Kusunoki, S., Shimizu, T., & Kanazawa, I. (1992). Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Annals of Neurology. https://doi.org/10.1002/ana.410310619

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.